These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 26177320)

  • 21. Diagnostic and prognostic assessments of adrenocortical carcinomas by pathological features, immunohistochemical markers and reticular histochemistry staining.
    Gan W; Han X; Gong Y; Yang Y; Wang C; Zhang Z
    Diagn Pathol; 2024 May; 19(1):71. PubMed ID: 38802933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myxoid and Sarcomatoid Variants of Adrenocortical Carcinoma: Analysis of Rare Variants in Single Tertiary Care Center.
    Sung TY; Choi YM; Kim WG; Lee YM; Kim TY; Shong YK; Kim WB; Song DE
    J Korean Med Sci; 2017 May; 32(5):764-771. PubMed ID: 28378549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sarcomatoid Adrenal Carcinoma: Case Report with Contribution to Pathogenesis.
    Saeger W; Mohren W; Behrend M; Iglauer P; Wilczak W
    Endocr Pathol; 2017 Jun; 28(2):139-145. PubMed ID: 27688079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Molecular genetic markers and criteria for the prediction of adrenocortical carcinoma].
    Selivanova LS; Roslyakova AA; Bogolyubova AV; Tertychnyi AS; Beltsevich DG; Abrosimov AY; Melnichenko GA
    Arkh Patol; 2019; 81(5):92-96. PubMed ID: 31626211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detailed genomic characterization identifies high heterogeneity and histotype-specific genomic profiles in adrenocortical carcinomas.
    Vatrano S; Volante M; Duregon E; Giorcelli J; Izzo S; Rapa I; Votta A; Germano A; Scagliotti G; Berruti A; Terzolo M; Papotti AM
    Mod Pathol; 2018 Aug; 31(8):1257-1269. PubMed ID: 29581542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Current criteria for the diagnosis of adrenocortical carcinoma].
    Selivanova LS; Roslyakova AA; Kovalenko YA; Bogolyubova AV; Tertychnyi AS; Beltsevich DG; Abrosimov AY; Melnichenko GA
    Arkh Patol; 2019; 81(3):66-73. PubMed ID: 31317933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adrenocortical carcinoma: review of the pathologic features, production of adrenal steroids, and molecular pathogenesis.
    Nakamura Y; Yamazaki Y; Felizola SJ; Ise K; Morimoto R; Satoh F; Arai Y; Sasano H
    Endocrinol Metab Clin North Am; 2015 Jun; 44(2):399-410. PubMed ID: 26038208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Giant nonfunctioning adrenocortical carcinoma: a case report and review of the literature.
    Almarzouq A; Asfar S; Hussain S; Al-Hunayan A; Aldousari S
    BMC Res Notes; 2014 Oct; 7():769. PubMed ID: 25361816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pitfalls in the diagnosis of adrenocortical tumors: a lesson from 300 consultation cases.
    Duregon E; Volante M; Bollito E; Goia M; Buttigliero C; Zaggia B; Berruti A; Scagliotti GV; Papotti M
    Hum Pathol; 2015 Dec; 46(12):1799-807. PubMed ID: 26472162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The argument for mitotic rate-based grading for the prognostication of adrenocortical carcinoma.
    Giordano TJ
    Am J Surg Pathol; 2011 Apr; 35(4):471-3. PubMed ID: 21383612
    [No Abstract]   [Full Text] [Related]  

  • 31. [Adrenocortical carcinoma: modern concepts of morphological diagnosis and classification].
    Urusova LS; Kletskaya IS; Porubayeva EE; Beltsevich DG
    Arkh Patol; 2023; 85(4):32-38. PubMed ID: 37530188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Weiss system for evaluating adrenocortical neoplasms: 25 years later.
    Lau SK; Weiss LM
    Hum Pathol; 2009 Jun; 40(6):757-68. PubMed ID: 19442788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The molecular basis of adrenocortical cancer.
    Lehmann T; Wrzesinski T
    Cancer Genet; 2012 Apr; 205(4):131-7. PubMed ID: 22559973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor Heterogeneity in Breast Cancer.
    Badve S; Gökmen-Polar Y
    Adv Anat Pathol; 2015 Sep; 22(5):294-302. PubMed ID: 26262511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adrenocortical carcinoma.
    Rodgers SE; Evans DB; Lee JE; Perrier ND
    Surg Oncol Clin N Am; 2006 Jul; 15(3):535-53. PubMed ID: 16882496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [123 I]Iodometomidate for molecular imaging of adrenocortical cytochrome P450 family 11B enzymes.
    Hahner S; Stuermer A; Kreissl M; Reiners C; Fassnacht M; Haenscheid H; Beuschlein F; Zink M; Lang K; Allolio B; Schirbel A
    J Clin Endocrinol Metab; 2008 Jun; 93(6):2358-65. PubMed ID: 18397978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genomic and expression profiling of adrenocortical carcinoma: application to diagnosis, prognosis and treatment.
    Bussey KJ; Demeure MJ
    Future Oncol; 2009 Jun; 5(5):641-55. PubMed ID: 19519204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oncocytic adrenocortical carcinoma--a rare pathological variant.
    Kalra S; Manikandan R; Srinivas BH
    BMJ Case Rep; 2015 Apr; 2015():. PubMed ID: 25911357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Roles of the pathologist in evaluating surrogate markers for medical therapy in adrenocortical carcinoma.
    Sasano H; Satoh F; Nakamura Y
    Endocr Pathol; 2014 Dec; 25(4):366-70. PubMed ID: 25252621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The reticulin algorithm for adrenocortical tumor diagnosis: a multicentric validation study on 245 unpublished cases.
    Duregon E; Fassina A; Volante M; Nesi G; Santi R; Gatti G; Cappellesso R; Dalino Ciaramella P; Ventura L; Gambacorta M; Dei Tos AP; Loli P; Mannelli M; Mantero F; Berruti A; Terzolo M; Papotti M
    Am J Surg Pathol; 2013 Sep; 37(9):1433-40. PubMed ID: 23774167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.